PortfoliosLab logoPortfoliosLab logo
SBFM vs. MSFT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SBFM vs. MSFT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sunshine Biopharma Inc (SBFM) and Microsoft Corporation (MSFT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SBFM achieves a -83.33% return, which is significantly lower than MSFT's -23.71% return. Over the past 10 years, SBFM has underperformed MSFT with an annualized return of -51.42%, while MSFT has yielded a comparatively higher 23.62% annualized return.


SBFM

1D
-3.76%
1M
-57.41%
YTD
-83.33%
6M
-85.14%
1Y
-85.76%
3Y*
-94.10%
5Y*
-77.19%
10Y*
-51.42%

MSFT

1D
-3.18%
1M
-12.24%
YTD
-23.71%
6M
-23.91%
1Y
-22.44%
3Y*
3.92%
5Y*
7.61%
10Y*
23.62%
*Multi-year figures are annualized to reflect compound growth (CAGR)

SBFM vs. MSFT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
SBFM
Sunshine Biopharma Inc
-83.33%-59.00%-99.45%-57.58%994.95%272.29%3,388.89%-97.19%-93.28%197.50%
MSFT
Microsoft Corporation
-23.71%15.58%12.93%58.19%-28.02%52.48%42.53%57.56%20.80%40.73%

Correlation

The correlation between SBFM and MSFT is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.14

Correlation (5Y)
Calculated over the trailing 5-year period

0.13

Correlation (10Y)
Calculated over the trailing 10-year period

0.06

Correlation (All Time)
Calculated using the full available price history since Oct 30, 2009

0.02

The correlation between SBFM and MSFT shifts across timeframes, from 0.02 (all time) to 0.14 (3 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

SBFM:

$8.52M

MSFT:

$2.73T

EPS

SBFM:

-$1.98

MSFT:

$16.79

PS Ratio

SBFM:

0.17

MSFT:

8.61

PB Ratio

SBFM:

0.37

MSFT:

6.60

Total Revenue (TTM)

SBFM:

$36.31M

MSFT:

$318.27B

Gross Profit (TTM)

SBFM:

$12.26M

MSFT:

$217.41B

EBITDA (TTM)

SBFM:

-$5.62M

MSFT:

$200.96B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SBFM vs. MSFT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SBFM
SBFM Risk / Return Rank: 66
Overall Rank
SBFM Sharpe Ratio Rank: 1414
Sharpe Ratio Rank
SBFM Sortino Ratio Rank: 77
Sortino Ratio Rank
SBFM Omega Ratio Rank: 55
Omega Ratio Rank
SBFM Calmar Ratio Rank: 44
Calmar Ratio Rank
SBFM Martin Ratio Rank: 11
Martin Ratio Rank

MSFT
MSFT Risk / Return Rank: 1111
Overall Rank
MSFT Sharpe Ratio Rank: 88
Sharpe Ratio Rank
MSFT Sortino Ratio Rank: 1010
Sortino Ratio Rank
MSFT Omega Ratio Rank: 1010
Omega Ratio Rank
MSFT Calmar Ratio Rank: 1717
Calmar Ratio Rank
MSFT Martin Ratio Rank: 1010
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SBFM vs. MSFT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sunshine Biopharma Inc (SBFM) and Microsoft Corporation (MSFT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SBFMMSFTDifference
Sharpe ratioReturn per unit of total volatility

+0.20

Sortino ratioReturn per unit of downside risk

-0.31

Omega ratioGain probability vs. loss probability

0.78

0.86

-0.08

Calmar ratioReturn relative to maximum drawdown

-0.95

-0.66

-0.28

Martin ratioReturn relative to average drawdown

-1.98

-1.32

-0.66

SBFM vs. MSFT - Sharpe Ratio Comparison

The current SBFM Sharpe Ratio is -0.66, which is comparable to the MSFT Sharpe Ratio of -0.87. The chart below compares the historical Sharpe Ratios of SBFM and MSFT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SBFM vs. MSFT - Drawdown Comparison

The maximum SBFM drawdown since its inception was -100.00%, which is greater than MSFT's maximum drawdown of -69.38%. Use the drawdown chart below to compare losses from any high point for SBFM and MSFT.


Loading charts...

Drawdown Indicators


SBFMMSFTDifference

Max Drawdown

Largest peak-to-trough decline

-100.00%

-69.38%

-30.62%

Max Drawdown (1Y)

Largest decline over 1 year

-90.68%

-33.91%

-56.77%

Max Drawdown (3Y)

Largest decline over 3 years

-99.98%

-33.91%

-66.07%

Max Drawdown (5Y)

Largest decline over 5 years

-100.00%

-37.15%

-62.85%

Max Drawdown (10Y)

Largest decline over 10 years

-100.00%

-37.15%

-62.85%

Current Drawdown

Current decline from peak

-100.00%

-31.80%

-68.20%

Average Drawdown

Average peak-to-trough decline

-88.84%

-21.79%

-67.05%

Ulcer Index

Depth and duration of drawdowns from previous peaks

43.21%

16.97%

+26.24%

Volatility

SBFM vs. MSFT - Volatility Comparison

Sunshine Biopharma Inc (SBFM) has a higher volatility of 56.48% compared to Microsoft Corporation (MSFT) at 11.08%. This indicates that SBFM's price experiences larger fluctuations and is considered to be riskier than MSFT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SBFMMSFTDifference

Volatility (1M)

Calculated over the trailing 1-month period

56.48%

11.08%

+45.40%

Volatility (6M)

Calculated over the trailing 6-month period

117.37%

22.93%

+94.44%

Volatility (1Y)

Calculated over the trailing 1-year period

129.50%

26.01%

+103.49%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

6,611.20%

26.78%

+6,584.42%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

4,763.88%

27.11%

+4,736.77%

Dividends

SBFM vs. MSFT - Dividend Comparison

SBFM has not paid dividends to shareholders, while MSFT's dividend yield for the trailing twelve months is around 0.97%.


PositionTTM20252024202320222021202020192018201720162015
MSFT
Microsoft Corporation
0.97%0.70%0.73%0.74%1.06%0.68%0.94%1.20%1.69%1.86%2.37%2.33%
SBFM
Sunshine Biopharma Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

SBFM vs. MSFT - Financials Comparison

This section allows you to compare key financial metrics between Sunshine Biopharma Inc and Microsoft Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B20222023202420252026
8.58M
82.89B
(SBFM) Total Revenue
(MSFT) Total Revenue
Values in USD except per share items

SBFM vs. MSFT - Profitability Comparison

The chart below illustrates the profitability comparison between Sunshine Biopharma Inc and Microsoft Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%20222023202420252026
35.3%
67.6%
Portfolio components
SBFM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Sunshine Biopharma Inc reported a gross profit of 3.03M and revenue of 8.58M. Therefore, the gross margin over that period was 35.3%.

MSFT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Microsoft Corporation reported a gross profit of 56.06B and revenue of 82.89B. Therefore, the gross margin over that period was 67.6%.

SBFM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Sunshine Biopharma Inc reported an operating income of -1.79M and revenue of 8.58M, resulting in an operating margin of -20.9%.

MSFT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Microsoft Corporation reported an operating income of 38.40B and revenue of 82.89B, resulting in an operating margin of 46.3%.

SBFM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Sunshine Biopharma Inc reported a net income of -2.14M and revenue of 8.58M, resulting in a net margin of -25.0%.

MSFT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Microsoft Corporation reported a net income of 31.78B and revenue of 82.89B, resulting in a net margin of 38.3%.


Frequently Asked Questions


SBFM and MSFT have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SBFM has higher volatility (56.48%) compared to MSFT (11.08%). In terms of maximum drawdown, SBFM dropped -100.00% vs MSFT's -69.38%.

SBFM currently has the higher Sharpe Ratio (-0.66 vs -0.87), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SBFM and MSFT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer